Claims for Patent: 10,105,337
✉ Email this page to a colleague
Summary for Patent: 10,105,337
| Title: | Fumarate ester pharmaceutical compositions |
| Abstract: | Described herein are pharmaceutical compositions comprising fumarate esters, methods for making the same, and methods for treating subjects in need thereof. In particular, oral pharmaceutical compositions comprising fumarate esters are described. |
| Inventor(s): | Tatyana Dyakonov, Sunil Agnihotri, Aqeel A. Fatmi |
| Assignee: | Banner Life Sciences LLC |
| Application Number: | US15/730,841 |
| Patent Claims: |
1. An oral immediate release pharmaceutical composition comprising a single phase non-aqueous vehicle comprising about 60 mg to about 200 mg of one or more fumarate esters or salts thereof having the formula: wherein R1 and R2, may be the same or different, and independently represent hydrogen or a linear, branched, or cyclic, saturated or unsaturated C1-20 alkyl radical, which may be optionally substituted with halogen, hydroxy, C1-4 alkoxy, nitro, or cyano. 2. The composition of claim 1, wherein R1 is C1-4 alkyl. 3. The composition of claim 1, wherein R1 is methyl. 4. The composition of claim 1, wherein R2 is C1-4 alkyl. 5. The composition of claim 1, wherein R2 is methyl. 6. The composition of claim 1, wherein R2 is hydrogen. 7. The composition of claim 1, wherein R1 is C1-4 alkyl and R2 is C1-4 alkyl. 8. The composition of claim 1, wherein R1 is methyl and R2 is methyl. 9. The composition of claim 1, wherein R1 is a C1-4 alkyl and R2 is hydrogen. 10. The composition of claim 1, wherein R1 is methyl and R2 is hydrogen. 11. The composition of claim 1, wherein the fumarate ester is: 12. The composition of claim 1, wherein the fumarate ester is: or a salt thereof. 13. The composition of claim 1, wherein the composition comprises mono- and di-glycerides, polyvinylpyrrolidone, and polyoxyl 40 hydrogenated castor oil. 14. The composition of claim 1, wherein the composition comprises lactic acid. 15. The composition of claim 1, wherein the composition comprises about 25% to about 50% of the one or more fumarate esters or salts thereof about 40% to about 54% of mono- and di-glycerides; about 1% to about 10% polyvinylpyrrolidone; about 2% to about 10% polyoxyl 40 hydrogenated castor oil; and about 5% lactic acid. 16. The composition of claim 1, wherein the composition is encapsulated in a capsule. 17. The composition of claim 1, wherein the composition is encapsulated in an enteric soft capsule. 18. The composition of claim 17, wherein the enteric soft capsule provides delayed release of the fumarate ester. 19. The composition of claim 1, wherein the fumarate ester is in the form of milled or micronized particles. 20. The composition of claim 1, wherein the composition is stable for at least 1 year at 25° C. |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
